Literature DB >> 10917775

No correlation in Epstein-Barr virus reactivation between serological parameters and viral load.

B C Gärtner, K Kortmann, M Schäfer, N Mueller-Lantzsch, U Sester, H Kaul, H Pees.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10917775      PMCID： PMC86846          DOI： 10.1128/JCM.38.6.2458-2458.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

1.  Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction.

Authors:  H J Wagner; G Bein; A Bitsch; H Kirchner
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

2.  Pathogenesis of chronic Epstein-Barr virus infection: detection of a virus strain with a high rate of lytic replication.

Authors:  M Jäger; N Prang; M Mitterer; C Larcher; H P Huemer; U Reischl; H Wolf; F Schwarzmann
Journal:  Br J Haematol       Date:  1996-12       Impact factor: 6.998

Review 3.  EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.

Authors:  J L McKnight; H Cen; S A Riddler; M C Breinig; P A Williams; M Ho; P S Joseph
Journal:  Leuk Lymphoma       Date:  1994-09

4.  Serological evidence for reactivation of EBV infection due to uraemic immunodeficiency.

Authors:  B Winkelspecht; N Mueller-Lantzsch; H Köhler
Journal:  Nephrol Dial Transplant       Date:  1997-10       Impact factor: 5.992

5.  Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia.

Authors:  M V Ragni; S H Belle; R A Jaffe; S L Duerstein; D C Bass; C W McMillan; E W Lovrien; L M Aledort; C T Kisker; S P Stabler
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113
  5 in total
  11 in total

Review 1.  Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.

Authors:  Ralf D Hess
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 2.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

3.  Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.

Authors:  Barbara C Gärtner; Hansjörg Schäfer; Katja Marggraff; Günter Eisele; Marco Schäfer; Dagmar Dilloo; Klaus Roemer; Hans-Jürgen Laws; Martina Sester; Urban Sester; Hermann Einsele; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.

Authors:  Mario Berth; Eugene Bosmans
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

5.  Performance of new enzyme-linked fluorescent assays for detection of Epstein-Barr virus specific antibodies in routine diagnostics.

Authors:  Christoph Koidl; Regina Riedl; Bettina Schweighofer; Sandra Fett; Michael Bozic; Egon Marth
Journal:  Wien Klin Wochenschr       Date:  2011-03-31       Impact factor: 1.704

6.  Long-term follow-up of Epstein-Barr virus viremia in pediatric recipients of renal transplants.

Authors:  Tahar Hadou; Jean Luc André; Rosine Bourquard; Marie Jeanne Krier-Coudert; Véronique Venard; Alain Le Faou
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

7.  Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.

Authors:  Barbara C Gärtner; Ralf D Hess; Dirk Bandt; Alexander Kruse; Axel Rethwilm; Klaus Roemer; Nikolaus Mueller-Lantzsch
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

8.  Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.

Authors:  Dasheng Zheng; Jun Wan; Yong Gu Cho; Leyao Wang; Chuang-Jiun Chiou; Shweta Pai; Crystal Woodard; Jian Zhu; Gangling Liao; Otoniel Martinez-Maza; Jiang Qian; Heng Zhu; Gary S Hayward; Richard F Ambinder; S Diane Hayward
Journal:  J Infect Dis       Date:  2011-10-11       Impact factor: 5.226

9.  Anti-citrullinated protein antibody response after primary EBV infection in kidney transplant patients.

Authors:  Lianne J N Kraal; Marieke L Nijland; Kristine L Germar; Dominique L P Baeten; Ineke J M Ten Berge; Cynthia M Fehres
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

10.  Comprehensive Evaluation of Hepatitis E Serology and Molecular Testing in a Large Cohort.

Authors:  Olympia E Anastasiou; Viktoria Thodou; Annemarie Berger; Heiner Wedemeyer; Sandra Ciesek
Journal:  Pathogens       Date:  2020-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.